PCSA 10-Q: SEC filing
Processa Pharmaceuticals
Filed with the SEC on · accession 0001493152-26-051827
PCSA filed a 10-Q (quarterly report) with the SEC on Nov 13, 2026. The quarterly report: unaudited results for the quarter plus management’s comments. The stock moved +0.5% by the first close after the filing.
Summary of the filing
Processa Pharmaceuticals filed its Q3 2026 Form 10-Q, reporting quarterly financial results and disclosing a merger agreement with Vidya Therapeutics Inc. involving the issuance of Series A Non-Voting Convertible Preferred Stock.
Key details
How PCSA stock reacted
Close before
$1.85
Nov 12, 2026
First close after
+0.54%
$1.86
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for PCSA, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for PCSA?
Click hereFrequently asked questions
What did PCSA file with the SEC on Nov 13, 2026?
PCSA filed a 10-Q (SEC filing). Processa Pharmaceuticals filed its Q3 2026 Form 10-Q, reporting quarterly financial results and disclosing a merger agreement with Vidya Therapeutics Inc. involving the issuance of Series A Non-Voting Convertible Preferred Stock.
How do I read a 10-Q?
The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.
How did PCSA stock react to this filing?
PCSA closed at $1.85 before the filing and $1.86 on Nov 13, 2026 (+0.54%).
Other PCSA SEC filings
- 8-K · SEC filingNov 5, 2026
- 8-K · Executive departureNov 4, 2026
- 8-K · Board changeOct 29, 2026
- EFFECT · Shelf registrationOct 23, 2026
- DEF 14A · Board changeOct 22, 2026
- S-3 · Shelf registrationOct 9, 2026
- 8-K · AcquisitionOct 5, 2026
- SCHEDULE 13G · SEC filingAug 18, 2026
- 10-Q · SEC filingAug 14, 2026
- 8-K · SEC filingAug 4, 2026
Get alerts when PCSA files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days